These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 21213405)
1. Inhibitory effects of resveratrol on platelet activation induced by thromboxane a(2) receptor agonist in human platelets. Yang Y; Wang X; Zhang L; An H; Zao Z Am J Chin Med; 2011; 39(1):145-59. PubMed ID: 21213405 [TBL] [Abstract][Full Text] [Related]
2. Resveratrol attenuates thromboxane A2 receptor agonist-induced platelet activation by reducing phospholipase C activity. Yang YM; Chen JZ; Wang XX; Wang SJ; Hu H; Wang HQ Eur J Pharmacol; 2008 Mar; 583(1):148-55. PubMed ID: 18291361 [TBL] [Abstract][Full Text] [Related]
3. Resveratrol attenuates adenosine diphosphate-induced platelet activation by reducing protein kinase C activity. Yang YM; Wang XX; Chen JZ; Wang SJ; Hu H; Wang HQ Am J Chin Med; 2008; 36(3):603-13. PubMed ID: 18543392 [TBL] [Abstract][Full Text] [Related]
4. The phospholipase C inhibitor U73122 inhibits phorbol ester-induced platelet activation. Lockhart LK; McNicol A J Pharmacol Exp Ther; 1999 May; 289(2):721-8. PubMed ID: 10215645 [TBL] [Abstract][Full Text] [Related]
5. Inhibitory effect of ethanol extract of Piper longum L. on rabbit platelet aggregation through antagonizing thromboxane A2 receptor. Iwashita M; Saito M; Yamaguchi Y; Takagaki R; Nakahata N Biol Pharm Bull; 2007 Jul; 30(7):1221-5. PubMed ID: 17603157 [TBL] [Abstract][Full Text] [Related]
6. [Suppressive effect in vitro of resveratrol on ADP induced human platelet aggregation and its active mechanism]. Yang YM; Wang XX; Wang SJ; Wang HQ; Chen JZ Yao Xue Xue Bao; 2008 Apr; 43(4):356-60. PubMed ID: 18664195 [TBL] [Abstract][Full Text] [Related]
7. An antithrombotic agent, NQ301, inhibits thromboxane A2 receptor and synthase activity in rabbit platelets. Jin YR; Cho MR; Lee KS; Lee JJ; Lim Y; Han XH; Oh KW; Hong JT; Yoo HS; Yun YP Basic Clin Pharmacol Toxicol; 2005 Sep; 97(3):162-7. PubMed ID: 16128910 [TBL] [Abstract][Full Text] [Related]
8. Protein kinase C- and calcium-regulated pathways independently synergize with Gi pathways in agonist-induced fibrinogen receptor activation. Quinton TM; Kim S; Dangelmaier C; Dorsam RT; Jin J; Daniel JL; Kunapuli SP Biochem J; 2002 Dec; 368(Pt 2):535-43. PubMed ID: 12215172 [TBL] [Abstract][Full Text] [Related]
10. 1, 6-di-O-caffeoyl-β-D-glucopyranoside, a natural compound from Callicarpa nudiflora Hook impairs P2Y Fu J; Zhu X; Wang W; Lu H; Zhang Z; Liu T; Xu H; Fu H; Ma S; Luo Y Phytomedicine; 2017 Dec; 36():273-282. PubMed ID: 29157825 [TBL] [Abstract][Full Text] [Related]
11. Augmentation of U46619 induced human platelet aggregation by aspirin. Kim JM; Koo YK; Jin J; Lee YY; Park S; Yun-Choi HS Platelets; 2009 Mar; 20(2):111-9. PubMed ID: 19235053 [TBL] [Abstract][Full Text] [Related]
12. Antiplatelet activity of carnosol is mediated by the inhibition of TXA2 receptor and cytosolic calcium mobilization. Lee JJ; Jin YR; Lim Y; Hong JT; Kim TJ; Chung JH; Yun YP Vascul Pharmacol; 2006 Sep; 45(3):148-53. PubMed ID: 16916624 [TBL] [Abstract][Full Text] [Related]
13. Rapid stimulation of tyrosine phosphorylation signals downstream of G-protein-coupled receptors for thromboxane A2 in human platelets. Minuz P; Fumagalli L; Gaino S; Tommasoli RM; Degan M; Cavallini C; Lecchi A; Cattaneo M; Lechi Santonastaso C; Berton G Biochem J; 2006 Nov; 400(1):127-34. PubMed ID: 16859489 [TBL] [Abstract][Full Text] [Related]
14. Molecular mechanism of thromboxane A(2)-induced platelet aggregation. Essential role for p2t(ac) and alpha(2a) receptors. Paul BZ; Jin J; Kunapuli SP J Biol Chem; 1999 Oct; 274(41):29108-14. PubMed ID: 10506165 [TBL] [Abstract][Full Text] [Related]
15. Inhibitory mechanisms of resveratrol in platelet activation: pivotal roles of p38 MAPK and NO/cyclic GMP. Shen MY; Hsiao G; Liu CL; Fong TH; Lin KH; Chou DS; Sheu JR Br J Haematol; 2007 Nov; 139(3):475-85. PubMed ID: 17868048 [TBL] [Abstract][Full Text] [Related]
16. TRA-418, a novel compound having both thromboxane A(2) receptor antagonistic and prostaglandin I(2) receptor agonistic activities: its antiplatelet effects in human and animal platelets. Yamada N; Miyamoto M; Isogaya M; Suzuki M; Ikezawa S; Ohno M; Otake A; Umemura K J Thromb Haemost; 2003 Aug; 1(8):1813-9. PubMed ID: 12911598 [TBL] [Abstract][Full Text] [Related]
17. Effect of losartan on human platelet activation. Guerra-Cuesta JI; Montón M; Rodríguez-Feo JA; Jiménez AM; González-Fernández F; Rico LA; García R; Gómez J; Farré J; Casado S; López-Farré A J Hypertens; 1999 Mar; 17(3):447-52. PubMed ID: 10100084 [TBL] [Abstract][Full Text] [Related]
18. Timosaponin AIII induces antiplatelet and antithrombotic activity via Gq-mediated signaling by the thromboxane A2 receptor. Cong Y; Wang L; Peng R; Zhao Y; Bai F; Yang C; Liu X; Wang D; Ma B; Cong Y Sci Rep; 2016 Dec; 6():38757. PubMed ID: 27934923 [TBL] [Abstract][Full Text] [Related]
19. Antiplatelet Activity of a Newly Synthesized Novel Ruthenium (II): A Potential Role for Akt/JNK Signaling. Khamrang T; Hung KC; Hsia CH; Hsieh CY; Velusamy M; Jayakumar T; Sheu JR Int J Mol Sci; 2017 Apr; 18(5):. PubMed ID: 28448438 [TBL] [Abstract][Full Text] [Related]
20. Mechanism for antiplatelet effect of onion: AA release inhibition, thromboxane A(2)synthase inhibition and TXA(2)/PGH(2)receptor blockade. Moon CH; Jung YS; Kim MH; Lee SH; Baik EJ; Park SW Prostaglandins Leukot Essent Fatty Acids; 2000 May; 62(5):277-83. PubMed ID: 10883058 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]